# Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations

> **NCT07338214** · PHASE1 · COMPLETED · sponsor: **Zealand Pharma** · enrollment: 48 (actual)

## Conditions studied

- Obesity & Overweight

## Interventions

- **DRUG:** Petrelintide

## Key facts

- **NCT ID:** NCT07338214
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-17
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07338214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07338214, "Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07338214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*